UBS AM’s Mineralys Therapeutics MLYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$330K Buy
24,404
+16,604
+213% +$225K ﹤0.01% 2520
2025
Q1
$124K Buy
+7,800
New +$124K ﹤0.01% 2592